Skip to content

The effect of Jollab beverage on fatigue and happiness in patients with multiple sclerosis

Investigation the effect of Jollab beverage on fatigue and happiness in patients with multiple sclerosis referring to the MS Association of Rafsanjan

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20150713023190N12
Enrollment
70
Registered
2022-05-23
Start date
2022-06-05
Completion date
Unknown
Last updated
2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis. Multiple sclerosis

Interventions

Intervention 1: Intervention group: In this group, patients will receive 45 ml of jolab beverage (including 10.5 cc rose , 15 mg saffron, 9.25 g brown sugar and 3.75 cc water) daily for 4 weeks. Inter

Sponsors

Rafsanjan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Age between 18-60 years old Satisfaction to participate in the study Getting a score above 36 from the Fatigue Severity Scale questionnaire Satisfaction for taking Jollab beverage or placebo Confirmation of multiple sclerosis by a neurologist

Exclusion criteria

Exclusion criteria: Having other neurological diseases except multiple sclerosis Allergy to medicinal plants especially saffron and rosa damascena Pregnancy Lactation

Design outcomes

Primary

MeasureTime frame
Fatigue. Timepoint: Before the intervention and 30 days after the Jollab beverage consumption. Method of measurement: Fatigue Severity Scale.;Happiness. Timepoint: Before the intervention and 30 days after the Jollab beverage consumption. Method of measurement: Oxford Happiness Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactTabandeh Sadeghi

Rafsanjan University of Medical Sciences

t.b_sadeghi@yahoo.com+98 34 3425 5900

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026